| pubmed-article:15514370 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15514370 | lifeskim:mentions | umls-concept:C0001675 | lld:lifeskim |
| pubmed-article:15514370 | lifeskim:mentions | umls-concept:C1518418 | lld:lifeskim |
| pubmed-article:15514370 | lifeskim:mentions | umls-concept:C0555198 | lld:lifeskim |
| pubmed-article:15514370 | lifeskim:mentions | umls-concept:C0060197 | lld:lifeskim |
| pubmed-article:15514370 | lifeskim:mentions | umls-concept:C0034897 | lld:lifeskim |
| pubmed-article:15514370 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:15514370 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:15514370 | pubmed:issue | 21 | lld:pubmed |
| pubmed-article:15514370 | pubmed:dateCreated | 2004-10-29 | lld:pubmed |
| pubmed-article:15514370 | pubmed:abstractText | Fenretinide induces apoptosis in malignant gliomas in vitro. This two-stage phase II trial was conducted to determine the efficacy of fenretinide in adults with recurrent malignant gliomas. | lld:pubmed |
| pubmed-article:15514370 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15514370 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15514370 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15514370 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15514370 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15514370 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15514370 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15514370 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15514370 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15514370 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15514370 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15514370 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15514370 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15514370 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15514370 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15514370 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15514370 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15514370 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15514370 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15514370 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15514370 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15514370 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15514370 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15514370 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:15514370 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:15514370 | pubmed:author | pubmed-author:HessKenneth... | lld:pubmed |
| pubmed-article:15514370 | pubmed:author | pubmed-author:YungW K... | lld:pubmed |
| pubmed-article:15514370 | pubmed:author | pubmed-author:PradosMichael... | lld:pubmed |
| pubmed-article:15514370 | pubmed:author | pubmed-author:GrovesMorris... | lld:pubmed |
| pubmed-article:15514370 | pubmed:author | pubmed-author:PuduvalliVina... | lld:pubmed |
| pubmed-article:15514370 | pubmed:author | pubmed-author:LevinVictor... | lld:pubmed |
| pubmed-article:15514370 | pubmed:author | pubmed-author:ChangSusan... | lld:pubmed |
| pubmed-article:15514370 | pubmed:author | pubmed-author:KuhnJohn GJG | lld:pubmed |
| pubmed-article:15514370 | pubmed:author | pubmed-author:JunckLarryL | lld:pubmed |
| pubmed-article:15514370 | pubmed:author | pubmed-author:CloughesyTimo... | lld:pubmed |
| pubmed-article:15514370 | pubmed:author | pubmed-author:NicholasM... | lld:pubmed |
| pubmed-article:15514370 | pubmed:author | pubmed-author:WenPatrickP | lld:pubmed |
| pubmed-article:15514370 | pubmed:author | pubmed-author:MehtaMinesh... | lld:pubmed |
| pubmed-article:15514370 | pubmed:author | pubmed-author:GilbertMark... | lld:pubmed |
| pubmed-article:15514370 | pubmed:author | pubmed-author:MeyersChristi... | lld:pubmed |
| pubmed-article:15514370 | pubmed:author | pubmed-author:ConradCharles... | lld:pubmed |
| pubmed-article:15514370 | pubmed:author | pubmed-author:ZwiebelJamesJ | lld:pubmed |
| pubmed-article:15514370 | pubmed:author | pubmed-author:LiebermanFran... | lld:pubmed |
| pubmed-article:15514370 | pubmed:author | pubmed-author:North... | lld:pubmed |
| pubmed-article:15514370 | pubmed:author | pubmed-author:LiuVivienV | lld:pubmed |
| pubmed-article:15514370 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15514370 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:15514370 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:15514370 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15514370 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15514370 | pubmed:pagination | 4282-9 | lld:pubmed |
| pubmed-article:15514370 | pubmed:dateRevised | 2011-9-22 | lld:pubmed |
| pubmed-article:15514370 | pubmed:meshHeading | pubmed-meshheading:15514370... | lld:pubmed |
| pubmed-article:15514370 | pubmed:meshHeading | pubmed-meshheading:15514370... | lld:pubmed |
| pubmed-article:15514370 | pubmed:meshHeading | pubmed-meshheading:15514370... | lld:pubmed |
| pubmed-article:15514370 | pubmed:meshHeading | pubmed-meshheading:15514370... | lld:pubmed |
| pubmed-article:15514370 | pubmed:meshHeading | pubmed-meshheading:15514370... | lld:pubmed |
| pubmed-article:15514370 | pubmed:meshHeading | pubmed-meshheading:15514370... | lld:pubmed |
| pubmed-article:15514370 | pubmed:meshHeading | pubmed-meshheading:15514370... | lld:pubmed |
| pubmed-article:15514370 | pubmed:meshHeading | pubmed-meshheading:15514370... | lld:pubmed |
| pubmed-article:15514370 | pubmed:meshHeading | pubmed-meshheading:15514370... | lld:pubmed |
| pubmed-article:15514370 | pubmed:meshHeading | pubmed-meshheading:15514370... | lld:pubmed |
| pubmed-article:15514370 | pubmed:meshHeading | pubmed-meshheading:15514370... | lld:pubmed |
| pubmed-article:15514370 | pubmed:meshHeading | pubmed-meshheading:15514370... | lld:pubmed |
| pubmed-article:15514370 | pubmed:meshHeading | pubmed-meshheading:15514370... | lld:pubmed |
| pubmed-article:15514370 | pubmed:meshHeading | pubmed-meshheading:15514370... | lld:pubmed |
| pubmed-article:15514370 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15514370 | pubmed:articleTitle | Phase II study of fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American Brain Tumor Consortium study. | lld:pubmed |
| pubmed-article:15514370 | pubmed:affiliation | Department of Neuro-Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Unit 431, Houston TX 77030, USA. vpuduval@mdanderson.org | lld:pubmed |
| pubmed-article:15514370 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15514370 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15514370 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:15514370 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15514370 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15514370 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15514370 | lld:pubmed |
